STAT5 Contributes to Interferon Resistance of Melanoma Cells

Lens, 2002, Interferon alfa therapy for malignant melanoma: A systematic review of randomized controlled trials, J. Clin. Oncol., 20, 1818, 10.1200/JCO.2002.07.070 Sabel, 2003, Pros and cons of adjuvant interferon in the treatment of melanoma, Oncologist, 8, 451, 10.1634/theoncologist.8-5-451 Ransohoff, 1998, Cellular responses to interferons and other cytokines: The JAK-STAT paradigm, N. Engl. J. Med., 338, 616, 10.1056/NEJM199802263380911 Aaronson, 2002, A road map for those who don’t know JAK-STAT, Science, 296, 1653, 10.1126/science.1071545 Bluyssen, 1995, Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses, Proc. Natl. Acad. Sci. USA, 92, 5645, 10.1073/pnas.92.12.5645 Levy, 2000, Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice, Oncogene, 19, 2505, 10.1038/sj.onc.1203480 Pansky, 2000, Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-alpha, Int. J. Cancer, 85, 720, 10.1002/(SICI)1097-0215(20000301)85:5<720::AID-IJC20>3.0.CO;2-O Yi, 2002, Anticancer activity of sodium stibogluconate in synergy with IFNs, J. Immunol., 169, 5978, 10.4049/jimmunol.169.10.5978 Wong, 1997, Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma, J. Biol. Chem., 272, 28779, 10.1074/jbc.272.45.28779 Wong, 1998, IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs, J. Immunol., 160, 5475, 10.4049/jimmunol.160.11.5475 Kovarik, 2003, Malignant melanoma associates with deficient IFN-induced STAT 1 phosphorylation, Int. J. Mol. Med., 12, 335 Boudny, 2003, Interferon inducibility of STAT 1 activation and its prognostic significance in melanoma patients, Folia Biol. (Praha), 49, 142 Chawla-Sarkar, 2002, Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1), J. Interferon Cytokine Res., 22, 603, 10.1089/10799900252982089 Jackson, 2003, The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell line, Melanoma Res., 13, 219, 10.1097/00008390-200306000-00001 Jaster, 1999, Role of STAT5 in interferon-alpha signal transduction in Ba/F3 cells, Cell. Signal., 11, 331, 10.1016/S0898-6568(98)00049-7 Matikainen, 1999, Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells, Blood, 93, 1980, 10.1182/blood.V93.6.1980.406k20_1980_1991 Su, 2000, Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol, J. Biol. Chem., 275, 12661, 10.1074/jbc.275.17.12661 Bowman, 2000, STATs in oncogenesis, Oncogene, 19, 2474, 10.1038/sj.onc.1203527 Wellbrock, 1998, Signalling by the oncogenic receptor tyrosine kinase Xmrk leads to activation of STAT5 in Xiphophorus melanoma, Oncogene, 16, 3047, 10.1038/sj.onc.1201844 Baudler, 1999, Specific activation of a STAT family member in Xiphophorus melanoma cells, Exp. Cell Res., 249, 212, 10.1006/excr.1999.4470 Leszczyniecka, 2003, Expression regulation and genomic organization of human polynucleotide phosphorylase, hPNPase(old-35), a Type I interferon inducible early response gene, Gene, 316, 143, 10.1016/S0378-1119(03)00752-2 Nakajima, 1996, A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells, EMBO J., 15, 3651, 10.1002/j.1460-2075.1996.tb00734.x Onishi, 1998, Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation, Mol. Cell. Biol., 18, 3871, 10.1128/MCB.18.7.3871 Matsumoto, 1997, CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation, Blood, 89, 3148, 10.1182/blood.V89.9.3148 Florenes, 1999, Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma, Oncogene, 18, 1023, 10.1038/sj.onc.1202382 Leszczyniecka, 2002, Identification and cloning of human polynucleotide phosphorylase, hPNPase old-35, in the context of terminal differentiation and cellular senescence, Proc. Natl. Acad. Sci. USA, 99, 16636, 10.1073/pnas.252643699 Ito, 1999, Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1, Blood, 93, 1456, 10.1182/blood.V93.5.1456 Hong, 2002, Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS, J. Clin. Invest., 110, 1503, 10.1172/JCI0215841 Krebs, 2000, SOCS: physiological suppressors of cytokine signaling, J. Cell Sci., 113, 2813, 10.1242/jcs.113.16.2813 Fujitani, 1997, An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT, Oncogene, 14, 751, 10.1038/sj.onc.1200907 Morcinek, 2002, Activation of STAT5 triggers proliferation and contributes to anti-apoptotic signalling mediated by the oncogenic Xmrk kinase, Oncogene, 21, 1668, 10.1038/sj.onc.1205148 Wagner, 2002, Interferon signaling is dependent on specific tyrosines located within the intracellular domain of IFNAR2c. Expression of IFNAR2c tyrosine mutants in U5A cells, J. Biol. Chem., 277, 1493, 10.1074/jbc.M108928200 Tanabe, 2005, Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes, J. Immunol., 174, 609, 10.4049/jimmunol.174.2.609 Kortylewski, 1999, Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1, Oncogene, 18, 3742, 10.1038/sj.onc.1202708 Stewart, 2001, Interferon-tau activates multiple signal transducer and activator of transcription proteins and has complex effects on interferon-responsive gene transcription in ovine endometrial epithelial cells, Endocrinology, 142, 98, 10.1210/endo.142.1.7891 Moriggl, 1996, Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype, Mol. Cell. Biol., 16, 5691, 10.1128/MCB.16.10.5691 Masuhara, 1997, Cloning and characterization of novel CIS family genes, Biochem. Biophys. Res. Commun., 239, 439, 10.1006/bbrc.1997.7484